Stock BDRL BLONDER TONGUE LABORATORIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Blonder Tongue Laboratories, Inc.

Equities

BDRL

US0936981085

Delayed OTC Markets
Other stock markets
 12:10:43 2024-04-16 pm EDT 		5-day change 1st Jan Change
0.115 USD -39.29% Intraday chart for Blonder Tongue Laboratories, Inc. -39.26% +41.23%
2023 Blonder Tongue Announces IP Failover Feature Added to NXG Video Delivery System CI
2023 Tranche Update on Blonder Tongue Laboratories, Inc.'s Equity Buyback Plan announced on February 13, 2007. CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Blonder Tongue Announces IP Failover Feature Added to NXG Video Delivery System
CI
BLONDER TONGUE LABORATORIES INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
AQ
Tranche Update on Blonder Tongue Laboratories, Inc.'s Equity Buyback Plan announced on February 13, 2007.
CI
Tranche Update on Blonder Tongue Laboratories, Inc.'s Equity Buyback Plan announced on July 24, 2002.
CI
Blonder Tongue Laboratories, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Blonder Tongue Laboratories, Inc. Auditor Raises 'Going Concern' Doubt
CI
BLONDER TONGUE LABORATORIES INC : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
Blonder Tongue Announces Demise of Eric Skolnik, Senior Vice President
CI
Blonder Tongue Announces Demise of Eric Skolnik, Chief Financial Officer; Appoints Michael Censoplano as Interim CFO
CI
BLONDER TONGUE LABORATORIES INC : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
Blonder Tongue Laboratories, Inc. Announces the Retirement of Stephen K. Necessary from the Board
CI
BLONDER TONGUE LABORATORIES INC : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
Blonder Tongue Laboratories, Inc. Announces President Changes
CI
Blonder Tongue Laboratories, Inc. Announces Chief Executive Officer Changes
CI
BLONDER TONGUE LABORATORIES INC : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
BLONDER TONGUE LABORATORIES INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
Tranche Update on Blonder Tongue Laboratories, Inc.'s Equity Buyback Plan announced on July 24, 2002.
CI
Tranche Update on Blonder Tongue Laboratories, Inc.'s Equity Buyback Plan announced on February 13, 2007.
CI
Transcript : Blonder Tongue Laboratories, Inc., Q3 2022 Earnings Call, Nov 04, 2022
Blonder Tongue Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BDRL Stock
  4. News Blonder Tongue Laboratories, Inc.